DWTX · Categories · Form 4

DWTX - SEC Form 4 insider transactions

Dogwood Therapeutics Inc. (DWTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for DWTX

• 51d
  SEC Form 4 filed by SVP OF OPERATIONS Grosswald Ralph

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 51d
  SEC Form 4 filed by Chief Financial Officer Walsh Angela

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 51d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Gendreau Roger Michael

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 51d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 142d
  SEC Form 4 filed by Chief Financial Officer Walsh Angela

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 142d
  SEC Form 4 filed by SVP OF OPERATIONS Grosswald Ralph

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 142d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 142d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Gendreau Roger Michael

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 152d
  Director Sealbond Ltd converted options into 24,453,588 shares (SEC Form 4)

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Gendreau Roger Michael

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by Director Whitley Richard James

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by SVP OF OPERATIONS Grosswald Ralph

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by Director Thomas John C

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by Director Keefer David R

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by Chief Financial Officer Walsh Angela

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 299d
  SEC Form 4 filed by Director De La Rosa Abel

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director Whitley Richard James

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director Keefer David R

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director Thomas John C

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 307d
  SEC Form 4 filed by Director De La Rosa Abel

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)
• 405d
  SEC Form 4 filed by Director Ck Life Sciences Intl (Holdings) Inc

  4 - Dogwood Therapeutics, Inc. (0001818844) (Issuer)

Other DWTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends